Citigroup’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4.15M | Buy |
|
|||||
|
2020
Q4 | $127K | Buy |
|
|||||
|
2020
Q3 | $6K | Sell |
|
|||||
|
2020
Q2 | $24K | Sell |
|
|||||
|
2020
Q1 | $23K | Buy |
|
|||||
|
2019
Q4 | $31K | Sell |
|
|||||
|
2019
Q3 | $139K | Buy |
|
|||||
|
2019
Q2 | $111K | Buy |
|
|||||
|
2019
Q1 | $180K | Sell |
|
|||||
|
2018
Q4 | $1.3M | Buy |
|
|||||
|
2018
Q3 | $745K | Buy |
|
|||||
|
2018
Q2 | $313K | Sell |
|
|||||
|
2018
Q1 | $362K | Sell |
|
|||||
|
2017
Q4 | $1.55M | Buy |
|
|||||
|
2017
Q3 | $1.05M | Sell |
|
|||||
|
2017
Q2 | $1.39M | Buy |
|
|||||
|
2017
Q1 | $1.17M | Sell |
|
|||||
|
2016
Q4 | $5.14M | Buy |
|
|||||
|
2016
Q3 | $842K | Buy |
|
|||||
|
2016
Q2 | $403K | Sell |
|
|||||
|
2016
Q1 | $970K | Buy |
|
|||||
|
2015
Q4 | $465K | Sell |
|
|||||
|
2015
Q3 | $602K | Buy |
|
|||||
|
2015
Q2 | $331K | Sell |
|
|||||
|
2015
Q1 | $2.06M | Buy |
|
|||||
|
2014
Q4 | $386K | Buy |
|
|||||
|
2014
Q3 | $87K | Sell |
|
|||||
|
2014
Q2 | $152K | Sell |
|
|||||
|
2014
Q1 | $210K | Buy |
|
|||||
|
2013
Q4 | $46K | Buy |
|